Where to Get STI Testing: Your Guide to Sexual Health Clinics and Resources

Maintaining your sexual health is a crucial part of overall well-being, and regular STI (Sexually Transmitted Infection) testing is a key component of that. If you’re sexually active, understanding where sti testing is available and recommended is essential for protecting yourself and your partners. This guide will walk you through various options for STI testing and outline who should be tested and for which infections, based on established health guidelines.

Understanding STI Testing Recommendations

National health organizations like the U.S. Preventive Services Task Force (USPSTF) and the Centers for Disease Control and Prevention (CDC) provide important recommendations for STI screening. These guidelines help healthcare providers and individuals understand when and for which STIs testing is most beneficial. Generally, anyone who is sexually active can benefit from regular STI testing. Knowing your status allows for timely treatment if needed, prevents further transmission, and promotes responsible sexual health practices.

Where Can You Get Tested for STIs?

Finding accessible and confidential STI testing is easier than you might think. Here are several reliable options:

Public Health Clinics

Public health clinics are often excellent resources for STI testing. They are typically government-funded and offer services at a reduced cost or even for free. Confidentiality is a priority at these clinics, ensuring your privacy and comfort. They are a great option for comprehensive sexual health services, including STI testing, treatment, and counseling. To find a public health clinic near you, search online for your local health department’s website.

Planned Parenthood and Family Planning Clinics

Organizations like Planned Parenthood are dedicated to providing accessible reproductive and sexual healthcare. STI testing is a core service they offer, along with contraception, and other related health services. Planned Parenthood clinics often operate on a sliding fee scale, making care affordable for individuals with varying income levels. They are known for their welcoming and non-judgmental environment.

Private Doctor’s Offices and Primary Care Physicians

You can also get STI testing through your regular doctor or primary care physician. This can be a convenient option as part of your routine health check-ups. Discuss your sexual health openly with your doctor, and they can recommend appropriate STI screenings based on your risk factors and sexual history. Testing through your doctor’s office integrates STI screening into your overall healthcare management.

Community Health Centers

Community Health Centers are federally funded health centers designed to provide care in underserved communities. They offer a wide range of services, including primary care, mental health, and importantly, STI testing and treatment. These centers are committed to providing accessible, affordable, and culturally competent care to everyone, regardless of their insurance status or ability to pay.

Online STI Testing Services

For individuals seeking discreet and convenient options, online STI testing services have emerged. These services allow you to order test kits online, collect samples at home, and send them to a lab for testing. Results are typically delivered online within a few days. However, it’s crucial to choose reputable online services and ensure they provide follow-up support and guidance if your results are positive. It’s important to remember that positive results from online tests still require consultation with a healthcare provider for proper diagnosis and treatment.

Specific STI Testing and Screening Guidelines

While regular STI testing is generally recommended for sexually active individuals, certain groups and infections have specific guidelines:

Chlamydia and Gonorrhea Testing

For sexually active women aged 25 and older, increased risk for chlamydial and gonococcal infections exists if they have risk factors. These include a new sexual partner, multiple partners, a partner with concurrent partners, inconsistent condom use, a previous STI, or a history of exchanging sex for money or drugs. Testing is particularly important for these individuals. Furthermore, extragenital infections (in the throat or rectum) are also possible for both men and women depending on sexual practices, highlighting the need for comprehensive testing based on individual risk.

Herpes (HSV-2) Testing

Type-specific HSV-2 serologic assays are useful in specific scenarios. These include recurrent or atypical genital symptoms with a negative HSV PCR or culture, clinical diagnosis without lab confirmation, or if a partner has genital herpes. However, routine HSV-2 serologic screening is not recommended for the general population. Individuals at higher risk, such as those presenting for STI evaluations, especially with a history of 10 or more lifetime partners, or those with HIV, might need to be assessed for genital herpes symptoms and considered for type-specific testing if symptoms are present.

Syphilis Testing

The USPSTF recommends syphilis screening for all adults and adolescents aged 15 to 65. Syphilis can have serious health consequences if left untreated, making broad screening a critical public health measure. Screening is also crucial for pregnant women to prevent congenital syphilis.

HIV Testing

Routine HIV screening is recommended for everyone aged 13 to 64, regardless of risk factors, as per USPSTF guidelines. For individuals with specific risk factors, such as men who have sex with men (MSM), more frequent testing (e.g., annually or even more often) is advised. Early detection and treatment of HIV are vital for managing the infection and preventing transmission.

HPV and Cervical Cancer Screening

While the original text mentions anal cancer screening in specific high-risk groups, it’s important to also consider HPV and cervical cancer screening, especially for women. Cervical cancer screening guidelines, including Pap tests and HPV tests, are well-established and crucial for preventing cervical cancer. These screenings are typically recommended starting at age 21 and should be continued based on age and risk factors, as outlined by organizations like the American Cancer Society and the USPSTF.

Hepatitis B and C Testing

Screening for Hepatitis B and Hepatitis C is also recommended in certain populations. Hepatitis B screening is recommended for pregnant women and individuals at increased risk. Hepatitis C screening is recommended for all adults aged 18 to 79 years, and especially for those with risk factors. Both Hepatitis B and C can be sexually transmitted, although transmission is less common than for some other STIs.

Anal Cancer Screening (for high-risk groups)

Although data is currently insufficient to recommend routine anal cancer screening for all at-risk populations, certain clinical centers do perform anal cytology screening for populations at increased risk, such as individuals with HIV, MSM, and those who engage in receptive anal intercourse. Abnormal cytology results may be followed up with high-resolution anoscopy (HRA) for further evaluation.

Conclusion

Knowing where sti testing is available and understanding the recommendations for different STIs are vital steps in taking control of your sexual health. Whether you choose a public health clinic, Planned Parenthood, your doctor’s office, a community health center, or a reputable online service, accessible and confidential testing options are available. Regular STI screening, coupled with open communication with your healthcare provider and partners, empowers you to make informed decisions and protect your well-being. Don’t hesitate to seek out testing and prioritize your sexual health today.

References:

1. U.S. Preventive Services Task Force. Screening for Chlamydia and Gonorrhea: U.S. Preventive Services Task Force Recommendation Statement. JAMA. 2021 Sept 14;326(10).949-956.
2. Workowski KA, Bachmann L, Chan P, Johnston C, Muzny C, Park I, Reno H, Zenilman J, Bolan G. Sexually Transmitted Infections, 2021. MMWR Recomm Rep 2021:70(No. RR-04):1-187.
3. Bamberger, DM, et al. Extragenital Gonorrhea and Chlamydia Among Men and Women According to Type of Sexual Exposure. Sex Transm Dis, 2019. 46(5): p. 329-334.
4. Chan PA, Robinette A, Montgomery M, et al. Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature. Infect Dis Obstet Gynecol. 2016.
5. Kirsten Bibbins-Domingo. USPSTF Recommendation Statement, Screening for Syphilis Infection in Nonpregnant Adults and Adolescents U.S. Preventive Services Task Force Recommendation Statement. JAMA June 7, 2016 Volume 315, Number 21: 2321-2327.
6. Branson BM, et al. Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Healthcare Settings. MMWR. 2006;55(No. RR-14):1-17.
7. Owens DK. U.S. Preventive Services Task Force. Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement. JAMA. 2019 321(23): 2326-2336.
8. Committee on Practice Bulletins—Gynecology. Practice bulletin no. 157: Cervical Cancer Screening and Prevention. Obstet Gynecol 2016;127:e1–20. PMID:26695583 https://doi.org/10.1097/ AOG.0000000000001263
9. Fontham ETH, Wolf AMD, Church TR, et al. Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society. CA Cancer J Clin 2020;70:321–46. PMID:32729638 https://doi.org/10.3322/caac.21628external icon
10. Curry SJ, et al. Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement. JAMA, 2018. 320(7): p. 674-686.
11. Schillie S, Vellozzi C, Reingold A, et al. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2018;67(No. RR-1). PMID:29939980 https://www.cdc.gov/mmwr/volumes/67/rr/rr6701a1.htm.
12. Screening for Hepatitis C Virus Infection in Adolescents and Adults U.S. Preventive Services Task Force Recommendation Statement U.S. Preventive Services Task Force Article Information JAMA. 2020;323(10):970-975. doi:10.1001/jama.2020.1123.
13. Screening for Syphilis Infection in Pregnant Women U.S. Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA September 4, 2018 Volume 320, Number 9.
14. Committee on Obstetric Practice HIV Expert Work Group. ACOG Committee opinion no. 752: Prenatal and Perinatal Human Immunodeficiency Virus Testing. Obstet Gynecol 2018;132:e138–42. PMID:30134428 https://doi.org/10.1097/AOG.0000000000002825
15. Henderson JT, Webber EM, Bean SI. Screening for Hepatitis B Infection in Pregnant Women: Updated Evidence Report and Systematic Review for the U.S. Preventive Services Task Force. JAMA. 2019;322(4):360–362.
16. Rietmeijer CA, Hopkins E, Geisler WM, Orr DP, Kent CK. Chlamydia trachomatis Positivity Rates Among Men Tested in Selected Venues in the United States: A Review of the Recent Literature. Sex Transm Dis 2008;35(Suppl):S8–18. PMID:18449072 https://doi.org/10.1097/ OLQ.0b013e31816938ba.
17. DiNenno EA, et al. Recommendations for HIV Screening of Gay, Bisexual, and Other Men Who Have Sex with Men – United States, 2017. MMWR Morb Mortal Wkly Rep, 2017. 66(31): p. 830-832.
18. Thompson MA, Horberg MA, Agwu AL, et al. Primary Care Guidelines for Persons With HIV: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America. CID. Nov 6 2020.
19. Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infections Diseases Society of America. Available at https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Adult_OI.pdf